Program Overview

On Monday April 4th - Tuesday April 5th the Cystic Fibrosis Foundation Therapeutics Development Network will host the Spring TDN 2022 Conference at the Gaylord Palms in Kissimmee, FL. 
 
This in-person conference is designed to offer training and information to benefit clinical research teams conducting CF clinical research and the patients participating in the research. Additionally, the meeting provides opportunities for teams to work together, network with other CF clinical researchers, and collaborate regionally to identify best practices and resources to improve the quality and efficiency of cystic fibrosis clinical research activities.
 
Registration is now closed for this event.
 
Please contact Rochelle.DelosSantos@seattlechildrens.org with any questions about the program.
 

Educational Objectives

  • Apply partnership enhancement program learnings to engage more effectively with potential research participants
  • Describe different types of genetic therapies and their potential benefits and risks to patients and potential study participants
  • Identify potential partners and resources to enable effective collaborations
  • Identify tools and resources to optimize clinical research 
  • Plan for and prioritize for upcoming CF clinical studies

Session Formats

Plenary Sessions

All plenary sessions will be recorded and available for viewing after the meeting. Plenary session format will be panel lectures providing educational content to attendees.

 

Small-group Breakouts 

Only the Hot Topic sessions will be recorded. All small group breakout sessions are designed to be more interactive and require attendee participation in discussions.

Agenda

 

 

Please navigate to our Resources page in order to view special group rates at Walt Disney World.

This activity has been designed to meet the educational needs of the TDN Clinical Researchers involved in the care of patients with Cystic Fibrosis.

This activity is jointly provided by Medical Education Resources and Seattle Children's Research Institute.

This activity is supported by an educational grant from the Cystic Fibrosis Foundation.